about
Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand.Discrepant amplification results during the development of an assay leads to reclassification of two AIDS reagent repository HIV-2 isolates as HIV-1.The External Quality Assurance Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-γ ELISpot) assayAnti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals.Evaluation of Performance of Two Rapid Tests for Detection of HIV-1 and -2 in High- and Low-Prevalence Populations in Nigeria.An Evaluation of Selected Populations for HIV-1 Vaccine Cohort Development in Nigeria.Evaluation of Hologic Aptima HIV-1 Quant Dx Assay on the Panther System on HIV Subtypes.Detection of human herpesvirus 6 in tissues involved by sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).Transfusion-transmitted human T-lymphotropic virus Type I infection in a United States military emergency whole blood transfusion recipient in Afghanistan, 2010.Laboratory evaluation of rapid test kits to detect hepatitis C antibody for use in predonation screening in emergency settings.Stability of Human Immunodeficiency Virus Serological Markers in Samples Collected as HemaSpot and Whatman 903 Dried Blood SpotsComparison of Detection Limits of Fourth- and Fifth-Generation Combination HIV Antigen-Antibody, p24 Antigen, and Viral Load Assays on Diverse HIV IsolatesA chemical method for introducing haptens onto DNA probesUse of PCR for detection of HIV-1 sequences in babies born to seropositive mothersDecreased Seroreactivity in Individuals Initiating Antiretroviral Therapy during Acute HIV Infection
P50
Q30828875-B2439ABD-ADD7-4A60-81B2-7415E400A6FEQ33567901-2BA96AB8-523D-44E1-AD05-A69578C78685Q33567901-4125C445-166A-4570-BA43-DE2EB810C058Q34066932-4DAAE9BB-92A7-4AA1-93C1-B277990D2F7EQ36043712-92EB1E84-C284-402E-8A78-7BC5835D3022Q36174038-4AF26D02-102A-494D-A847-415A8B43FB85Q36218713-D33033B8-4C26-4488-ACFB-84F900A53F5EQ37280582-97D1D681-311B-46A8-B190-B03188C6EE03Q41612403-A3A0CD40-6974-4B6B-8E6B-02475462B48BQ41971357-93124981-21AC-4329-AAF8-37BC9129AF3BQ44113629-67176276-B99E-4C20-AD5E-76A39BF70D07Q58698887-EA3ACF1D-FC21-4AFA-A578-CC8650CD2C88Q59360630-89B4AFE2-802E-41AB-82E1-1E601BE1709FQ68445450-B7E5B8BC-C788-4410-B6A5-7D4D48F22BE9Q72672550-76AAFEC7-79C5-4FBE-8B65-C857127DFA30Q92883670-703E4B7F-E73C-4AC0-AF88-361F20AC34AE
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mark M. Manak
@ast
Mark M. Manak
@en
Mark M. Manak
@es
Mark M. Manak
@nl
Mark M. Manak
@sl
type
label
Mark M. Manak
@ast
Mark M. Manak
@en
Mark M. Manak
@es
Mark M. Manak
@nl
Mark M. Manak
@sl
prefLabel
Mark M. Manak
@ast
Mark M. Manak
@en
Mark M. Manak
@es
Mark M. Manak
@nl
Mark M. Manak
@sl
P214
P106
P1153
6701774155
P214
P271
DA04440027
P31
P496
0000-0002-9217-9129